Thumbnail

1.6 million excess Black deaths owed to inequities in cardiac care, JACC report card reveals

A JACC report card highlights excess cardiovascular mortality among Black Americans and "persistent and tragic inequities" in cardiovascular care.

The ASNC team at the 2024 AMA meeting, Georgia Lawrence, JD, ASNC director of regulatory affairs; Suman Tandon, MD, FASNC, delegate to the AMA HOD and cardiac imager at NYU Langone; and Kathy Flood, ASNC CEO. #AMA #AMA24 #AMA2024 #AMAHOD #ASNC

ASNC supports AMA effort to limit use of AI in prior authorization decisions

The American Society of Nuclear Cardiology (ASNC) supports an AMA policy that condemns the use AI to make prior authorization decisions rather than a doctor or clinician.

How long do wearable cardiac monitors record data?

Long-term continuous monitoring (LTCM) wearable devices now make up 40% or more of the remote ECG monitoring market due to ease of use and collection of more data.

Video interview with Matthew Reynolds, MD, who shares data on largest wearable ambulatory cardiac monitoring studies to date from the EXCALIBER and CAMELOT trials at HRS 2024. #HRS #HRS2024 #Remotemonitoring

First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage 

Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.

More than 5,600 cardiac ultrasound measurements are now automated using artificial intelligence in the new Siemens Acuson Origin echocardiography system. It is the first echo system to use AI to help automate and anticipate next actions to greatly speed workfor and increase reproducibility between sonographers. Photo by Dave Fornell at ESC 2023

Cardiovascular ultrasound innovations being showcased at ASE 2024 meeting

New cardiac ultrasound advances, from AI to completely study workflow, new 3D/4D catheters, virtual reality simulators, to robot-assisted ultrasound, will be presented on the expo floor of ASE 2024 this weekend in Portland.

The central illustration from a study that shows the impact of ECG AI algorithm study case and control selection to train artificial intelligence to better screening patients for cardiac amyloidosis. Image courtesy of JACC Advances.

Using ECG AI to find the cardiac amyloidosis needles in the haystack

Early detection of cardiac amyloidosis is leads to the best outcomes, but it is often missed until later stages. AI is being developed to help detect these patients earlier using ECG and echo.

There has been a growing shortage of cardiologists the past several years, but this has accelerated due to burnout from the pandemic, falling reimbursements and increasing administrative burdens. This prompted a joint session on this topic with the ACC and the Heart Rhythm Society at HRS 2024, with ACC President Cathie Biga, MSN, FACC, president and CEO of Cardiovascular Management of Illinois, former ACC president Ed Fry, MD, chair of the Ascension National Cardiovascular Service Line, and EP Parin Patel.

Addressing staffing shortages in cardiology

ACC President Cathie Biga, MSN, RN, Edward Fry, MD, and electrophysiologist Parin Patel, MD, discuss the growing cardiologist shortage.

Thumbnail

Even moderate alcohol use increases risk of high blood pressure, new meta-analysis confirms

Researchers explored data from 23 different studies, identifying a “positive and almost linear association” between alcohol consumption and hypertension. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup